Bioinformatics analysis to screen key genes in papillary thyroid carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Genomics

Background:

• Papillary thyroid carcinoma (PTC) is the most common thyroid cancer, with increasing incidence.
• The molecular mechanisms driving PTC remain poorly understood, hindering accurate diagnosis.
• Identifying reliable prognostic biomarkers is crucial for effective patient management.

Purpose of the Study:

• To elucidate the molecular mechanisms underlying PTC.
• To identify key genes and pathways implicated in PTC pathogenesis.
• To discover potential prognostic biomarkers for clinical diagnosis.

Main Methods:

• Integrated analysis of four Gene Expression Omnibus (GEO) microarray datasets (GSE33630, GSE27155, GSE3467, GSE3678).
• Identification and analysis of differentially expressed genes (DEGs) between PTC and healthy thyroid tissue.
• Gene Ontology, pathway enrichment, and protein-protein interaction (PPI) network analyses were performed.
• Receiver operating characteristic (ROC) curve analysis was used to evaluate predictive accuracy.

Main Results:

• A total of 153 DEGs were identified: 66 upregulated and 87 downregulated in PTC.
• DEGs were significantly enriched in cancer-related pathways, including the phosphoinositide 3-kinase-AKT signaling pathway.
• Key genes such as acetyl-CoA carboxylase beta, cyclin D1, BCL2, and serpin peptidase inhibitor clade A member 1 were identified via PPI network analysis.
• The identified DEGs demonstrated excellent predictive performance in ROC analysis.

Conclusions:

• The study identified crucial genes and pathways involved in PTC progression.
• These findings highlight potential novel biomarkers for the clinical diagnosis and prognosis of papillary thyroid carcinoma.
• Further research into these molecular players could improve understanding and treatment strategies for PTC.